Imaging of brain tumors with diffusion-weighted and diffusion tensor MR imaging

Magnetic Resonance Imaging Clinics of North America

Volumn 11, Issue 3, 2003, Pages 379-401

  Barboriak, Daniel P ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL;

BRAIN ABSCESS; BRAIN ARACHNOID CYST; BRAIN RADIOGRAPHY; BRAIN TUMOR; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CLINICAL EXAMINATION; DIFFUSION TENSOR IMAGING; DIFFUSION WEIGHTED IMAGING; EPIDERMOID TUMOR; GLIOBLASTOMA; HUMAN; INTRACRANIAL TUMOR; LYMPHOMA; MEDICAL SPECIALIST; MENINGIOMA; METASTASIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PEDIATRICS; POSTERIOR FOSSA; PREDICTION; PREOPERATIVE PERIOD; REVIEW; SIDE EFFECT; TREATMENT OUTCOME; TREATMENT PLANNING; WHITE MATTER;

EID: 0345307805     PISSN: 10649689     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1064-9689(03)00065-5     Document Type: Review

References (80)

1. Einstein A. Investigation on the theory of the brownian movement. New York: Dover; 1956.
2. Schaefer PW. Applications of DWI in clinical neurology. J Neurol Sci 2001;186(Suppl 1):S25-35.
3. Kallmes DF, Provenzale JM, Cloft HJ, McClendon RE. Typical and atypical MR imaging features of intracranial epidermoid tumors. Am J Roentgenol 1997;169(3):883-7.
4. Ikushima I, Korogi Y, Hirai T, et al. MR of epidermoids with a variety of pulse sequences. Am J Neuroradiol 1997;18(7):1359-63.
5. Dutt SN, Mirza S, Chavda SV, Irving RM. Radiologic differentiation of intracranial epidermoids from arachnoid cysts. Otol Neurotol 2002;23(1):84-92.
6. Ide C, De Coene B, Gilliard C, et al. Hemorrhagic arachnoid cyst with third nerve paresis: CT and MR findings. Am J Neuroradiol 1997;18(8): 1407-10.
7. Yamakami I, Kobayashi E, Saeki N, Yamaura A. Double echo steady state MR imaging of epidermoids. J Clin Neurosci 2002;9(1):69-71.
8. Chen S, Ikawa F, Kurisu K, Arita K, Takaba J, Kanou Y. Quantitative MR evaluation of intracranial epidermoid tumors by fast fluid-attenuated inversion recovery imaging and echo-planar diffusion-weighted imaging. Am J Neuroradiol 2001;22(6):1089-96.
9. Annet L, Duprez T, Grandin C, Dooms G, Collard A, Cosnard G. Apparent diffusion coefficient measurements within intracranial epidermoid cysts in six patients. Neuroradiology 2002;44(4):326-8.
10. Louis D, Scheithauer B, Budka H, von Deimling A, Kepes J. Meningiomas. In: Kleihues P, Cavenee W, editors. World Health Organization classification of tumours: pathology and genetics of tumours of the central nervous system. Lyon, France: IARC Press; 2000. p. 176-84.
11. Ayerbe J, Lobato RD, de la Cruz J, et al. Risk factors predicting recurrence in patients operated on for intracranial meningioma. A multivariate analysis. Acta Neurochir (Wien) 1999;141(9):921-32.
12. Filippi CG, Edgar MA, Ulug AM, Prowda JC, Heier LA, Zimmerman RD. Appearance of meningiomas on diffusion-weighted images: correlating diffusion constants with histopathologic findings. Am J Neuroradiol 2001;22(1):65-72.
13. Kimura T, Sako K, Gotoh T, Tanaka K, Tanaka T. In vivo single-voxel proton MR spectroscopy in brain lesions with ring-like enhancement. Biomed 2001;14(6):339-49.
14. Bergui M, Zhong J, Bradac GB, Sales S. Diffusion-weighted images of intracranial cyst-like lesions. Neuroradiology 2001;43(10):824-9.
15. Chang SC, Lai PH, Chen WL, et al. Diffusion-weighted MRI features of brain abscess and cystic or necrotic brain tumors: comparison with conventional MRI. Clin Imaging 2002;26(4):227-36.
16. Chan JH, Tsui EY, Chau LF, et al. Discrimination of an infected brain tumor from a cerebral abscess by combined MR perfusion and diffusion imaging. Comput Med Imaging Graph 2002;26(1):19-23.
17. Desprechins B, Stadnik T, Koerts G, Shabana W, Breucq C, Osteaux M. Use of diffusion-weighted MR imaging in differential diagnosis between intracerebral necrotic tumors and cerebral abscesses. Am J Neuroradiol 1999;20(7):1252-7.
18. Lai PH, Ho JT, Chen WL, et al. Brain abscess and necrotic brain tumor: discrimination with proton MR spectroscopy and diffusion-weighted imaging. Am J Neuroradiol 2002;23(8):1369-77.
19. Guzman R, Barth A, Lovblad K, et al. Use of diffusion-weighted magnetic resonance imaging in differentiating purulent brain processes from cystic brain tumors. J Neurosurg 2002;97(5):1001-7.
20. Ebisu T, Tanaka C, Umeda M, et al. Discrimination of brain abscess from necrotic or cystic tumors by diffusion-weighted echo planar imaging. Magn Reson Imaging 1996;14(9):1113-6.
21. Rusakov DA, Kullmann DM. Geometric and viscous components of the tortuosity of the extracellular space in the brain. Proc Natl Acad Sci USA 1998;95(15):8975-80.
22. Kim YJ, Chang KH, Song IC, et al. Brain abscess and necrotic or cystic brain tumor: discrimination with signal intensity on diffusion-weighted MR imaging. Am J Roentgenol 1998;171(6):1487-90.
23. Park SH, Chang KH, Song IC, Kim YJ, Kim SH, Han MH. Diffusion-weighted MRI in cystic or necrotic intracranial lesions. Neuroradiology 2000;42(10):716-21.
24. Guo AC, Provenzale JM, Cruz LC Jr., Petrella JR. Cerebral abscesses: investigation using apparent diffusion coefficient maps. Neuroradiology 2001;43(5):370-4.
25. Hartmann M, Jansen O, Heiland S, Sommer C, Munkel K, Sartor K. Restricted diffusion within ring enhancement is not pathognomonic for brain abscess. Am J Neuroradiol 2001;22(9):1738-42.
26. Holtas S, Geijer B, Stromblad LG, Maly-Sundgren P, Burtscher IM. A ring-enhancing metastasis with central high signal on diffusion-weighted imaging and low apparent diffusion coefficients. Neuroradiology 2000;42(11):824-7.
27. Tsui E, Chan J, Cheung Y, Lai K, Fong D, Ng S. Evaluation of cerebral abscesses by diffusion-weighted MR imaging and MR spectroscopy. Comput Med Imaging Graph 2002;26(5):347-51.
28. Tung GA, Evangelista P, Rogg JM, Duncan 3rd JA. Diffusion-weighted MR imaging of rim-enhancing brain masses: is markedly decreased water diffusion specific for brain abscess? Am J Roentgenol 2001;177(3):709-12.
29. Leuthardt EC, Wippold FJ, Oswodo MC, Rich KM. Diffusion-weighted MR imaging in the preoperative assessment of brain abscesses. Surg Neurol 2002;58(6):395-402.
30. Mori H, Abe O, Aoki S, et al. Hemorrhagic brain metastases with high signal intensity on diffusion-weighted MR images. Acta Radiol 2002;43(6):563-6.
31. Li X, Lu Y, Pirzkall A, McKnight T, Nelson SJ. Analysis of the spatial characteristics of metabolic abnormalities in newly diagnosed glioma patients. J Magn Reson Imaging 2002;16(3):229-37.
32. McKnight TR, von dem Bussche MH, Vigneron DB, et al. Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence. J Neurosurg 2002;97(4):794-802.
33. Yang D, Korogi Y, Sugahara T, et al. Cerebral gliomas: prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRI. Neuroradiology 2002;44(8):656-66.
34. Uematsu H, Maeda M, Sadato N, et al. Measurement of the vascularity and vascular leakage of gliomas by double-echo dynamic magnetic resonance imaging: a preliminary study. Invest Radiol 2002;37(10):571-6.
35. Ludemann L, Grieger W, Wurm R, Budzisch M, Hamm B, Zimmer C. Comparison of dynamic contrast-enhanced MRI with WHO tumor grading for gliomas. Eur Radiol 2001;11(7):1231-41.
36. Sugahara T, Korogi Y, Kochi M, et al. Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging 1999;9(1):53-60.
37. Kono K, Inoue Y, Nakayama K, et al. The role of diffusion-weighted imaging in patients with brain tumors. Am J Neuroradiol 2001;22(6):1081-8.
38. Sadeghi N, Camby I, Goldman S, et al. Effect of hydrophilic components of the extracellular matrix on quantifiable diffusion-weighted imaging of human gliomas: preliminary results of correlating apparent diffusion coefficient values and hyaluronan expression level. Am J Roentgenol 2003;181(1):235-41.
39. Gupta RK, Cloughesy TF, Sinha U, et al. Relationships between choline magnetic resonance spectroscopy, apparent diffusion coefficient and quantitative histopathology in human glioma. J Neurooncol 2000;50(3):215-26.
40. Stadnik TW, Chaskis C, Michotte A, et al. Diffusion-weighted MR imaging of intracerebral masses: comparison with conventional MR imaging and histologic findings. Am J Neuroradiol 2001;22(5):969-76.
41. Castillo M, Smith JK, Kwock L, Wilber K. Apparent diffusion coefficients in the evaluation of high-grade cerebral gliomas. Am J Neuroradiol 2001;22(1):60-4.
42. Lu S, Ahn D, Johnson G, Cha S. Peritumoral diffusion tensor imaging of high-grade gliomas and metastatic brain tumors. Am J Neuroradiol 2003;24(5):937-41.
43. Jellison BJ, Wu Y, Field AS, Hasan KM, Alexander AL, Badie B. Diffusion tensor imaging metrics for tissue characterization: discriminating vasogenic edema from infiltrating tumor. Paper presented at: American Society of Neuroradiology 41st Annual Meeting, 2003; Washington, DC.
44. McGraw P, Liang L, Provenzale JM. Comparison of ADC and FA values in normal appearing white matter adjacent to peritumoral edema in high-grade glioma and meningioma tumors. Paper presented at: American Society of Neuroradiology 41st Annual Meeting, 2003; Washington, DC.
45. Mulkern R, Gudbjartsson H, Westin C, et al. Multicomponent apparent diffusion coefficients in human brain. Biomed 1999;12(1):51-62.
46. Maier SE, Bogner P, Bajzik G, et al. Normal brain and brain tumor: multicomponent apparent diffusion coefficient line scan imaging. Radiology 2001;219(3):842-9.
47. Olson JE, Janney CA, Rao RD, et al. The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis. Cancer 2002;95(7):1504-10.
48. Guo AC, Cummings TJ, Dash RC, Provenzale JM. Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. Radiology 2002;224(1):177-83.
49. Okamoto K, Ito J, Ishikawa K, Sakai K, Tokiguchi S. Diffusion-weighted echo-planar MR imaging in differential diagnosis of brain tumors and tumor-like conditions. Eur Radiol 2000;10(8):1342-50.
50. Camacho DLA, Smith JK, Castillo M. Differentiation of toxoplasmosis and lymphoma in AIDS patients by using apparent diffusion coefficients. Am J Neuroradiol 2003;24(4):633-7.
51. Gauvain KM, McKinstry RC, Mukherjee P, et al. Evaluating pediatric brain tumor cellularity with diffusion-tensor imaging. Am J Roentgenol 2001, 177(2):449-54.
52. Klisch J, Husstedt H, Hennings S, von Velthoven V, Pagenstecher A, Schumacher M. Supratentorial primitive neuroectodermal tumours: diffusion-weighted MRI, Neuroradiology 2000;42(6):393-8.
53. Erdem E, Zimmerman RA, Haselgrove JC, Bilaniuk LT, Hunter JV. Diffusion-weighted imaging and fluid attenuated inversion recovery imaging in the evaluation of primitive neuroectodermal tumors. Neuroradiology 2001;43(11):927-33.
54. Wilke M, Eidenschink A, Muller-Weihrich S, Auer DP. MR diffusion imaging and 1H spectroscopy in a child with medulloblastoma. A case report. Acta Radiol 2001;42(1):39-42.
55. Quadery FA, Okamoto K. Diffusion-weighted MRI of haemangioblastomas and other cerebellar tumours. Neuroradiology 2003;45(4):212-9.
56. Ito R, Mori S, Melhem ER. Diffusion tensor brain imaging and tractography. Neuroimaging Clin N Am 2002;12(1):1-19.
57. Tournier JD, Calamante F, King MD, Gadian DG, Connelly A. Limitations and requirements of diffusion tensor fiber tracking: an assessment using simulations. Magn Reson Med 2002;47(4):701-8.
58. Kamada K, Houkin K, Iwasaki Y, et al. Rapid identification of the primary motor area by using magnetic resonance axonography. J Neurosurg 2002;97(3):558-67.
59. Mori S, Crain BJ, Chacko VP, van Zijl PC. Three-dimensional tracking of axonal projections in the brain by magnetic resonance imaging. Ann Neurol 1999;45(2):265-9.
60. Terajima K, Nakada T. EZ-tracing: a new ready-to-use algorithm for magnetic resonance tractography. J Neurosci Methods 2002;116(2):147-55.
61. Holodny AI, Schwartz TH, Ollenschleger M, Liu WC, Schulder M. Tumor involvement of the corticospinal tract: diffusion magnetic resonance tractography with intraoperative correlation. J Neurosurg 2001;95(6):1082.
62. Mori S, Frederiksen K, van Zijl PC, et al. Brain white matter anatomy of tumor patients evaluated with diffusion tensor imaging. Ann Neurol 2002;51(3):377-80.
63. Witwer BP, Moftakhar R, Hasan KM, et al. Diffusion-tensor imaging of white matter tracts in patients with cerebral neoplasm. J Neurosurg 2002;97(3):568-75.
64. Coenen VA, Krings T, Mayfrank L, et al. Three-dimensional visualization of the pyramidal tract in a neuronavigation system during brain tumor surgery: first experiences and technical note. Neurosurgery 2001;49(1):86-92.
65. Holodny AI, Ollenschleger MD, Liu WC, Schulder M, Kalnin AJ. Identification of the corticospinal tracts achieved using blood-oxygen-level-dependent and diffusion functional MR imaging in patients with brain tumors. Am J Neuroradiol 2001;22(1): 83-8.
66. Krings T, Reinges MH, Thiex R, Gilsbach JM, Thron A. Functional and diffusion-weighted magnetic resonance images of space-occupying lesions affecting the motor system: imaging the motor cortex and pyramidal tracts. J Neurosurg 2001;95(5):816-24.
67. Dechambre S, Duprez T, Lecouvet F, Raftopoulos C, Gosnard G. Diffusion-weighted MRI postoperative assessment of an epidermoid tumour in the cerebellopontine angle. Neuroradiology 1999;41(11):829-31.
68. Chenevert T, McKeever P, Ross B. Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging. Clin Cancer Res 1997;3(9):1457-66.
69. Poptani H, Puumalainen A, Grohn O, et al. Monitoring thymidine kinase and ganciclovir-induced changes in rat malignant glioma in vivo by nuclear magnetic resonance imaging. Cancer Gene Ther 1998;5(2):101-9.
70. Stegman L, Rehemtulla A, Hamstra D, et al. Diffusion MRI detects early events in the response of a glioma model to the yeast cytosine deaminase gene therapy strategy. Gene Ther 2000;7(12):1005-10.
71. Kauppinen RA. Monitoring cytotoxic tumour treatment response by diffusion magnetic resonance imaging and proton spectroscopy. NMR Biomed 2002;15(1):6-17.
72. Chenevert TL, Stegman LD, Taylor JM, et al. Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J Natl Cancer Inst 2000;92(24):2029-36.
73. Mardor Y, Roth Y, Lidar Z, et al. Monitoring response to convection-enhanced taxol delivery in brain tumor patients using diffusion-weighted magnetic resonance imaging. Cancer Res 2001;61(13):4971-3.
74. Singh S, Leeds N. Postoperative diffusion imaging in the setting of craniotomies for brain masses: incidence of ischemia. Paper presented at: American Society of Neuroradiology 40th Annual Meeting, 2002; Vancouver, BC.
75. Valk PE, Dillon WP. Radiation injury of the brain. Am J Neuroradiol 1991;12(1):45-62.
76. Fujikawa A, Tsuchiya K, Katase S, Kurosaki Y, Hachiya J. Diffusion-weighted MR imaging of Carmofur-induced leukoencephalopathy. Eur Radiol 2001;11(12):2602-6.
77. Khong PL, Kwong DL, Chan GC, Sham JS, Chan FL, Ooi GC. Diffusion-tensor imaging for the detection and quantification of treatment-induced white matter injury in children with medulloblastoma: a pilot study. Am J Neuroradiol 2003;24(4):734-40.
78. Mitchell WG, Fishman LS, Miller JH, et al. Stroke as a late sequela of cranial irradiation for childhood brain tumors. J Child Neurol 1991;6(2): 128-33.
79. Giese A, Westphal M. Glioma invasion in the central nervous system. Neurosurgery 1996;39(2): 235-50; discussion 250-2.
80. de Bouard S, Christov C, Guillamo JS, et al. Invasion of human glioma biopsy specimens in cultures of rodent brain slices: a quantitative analysis. J Neurosurg 2002;97(1):169-76.